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Abstract
Background: Under appropriate culture conditions, undifferentiated embryonic stem (ES) cells can undergo multiple self-
renewal cycles without loss of pluripotency suggesting they must be equipped with specific defense mechanisms to ensure
sufficient genetic stability during self-renewal expansion. The ATP binding cassette transporter ABCG2 is expressed in a wide
variety of somatic and embryonic stem cells. However, whether it plays an important role in stem cell maintenance remains
to be defined.
Methodology/Principal Findings: Here we provide evidence to show that an increase in the level of ABCG2 was observed
accompanied by ES colony expansion and then were followed by decreases in the level of protoporphyrin IX (PPIX) indicating
that ABCG2 plays a role in maintaining porphyrin homoeostasis. RNA-interference mediated inhibition of ABCG2 as well as
functional blockage of ABCG2 transporter with fumitremorgin C (FTC), a specific and potent inhibitor of ABCG2, not only
elevated the cellular level of PPIX, but also arrest the cell cycle and reduced expression of the pluripotent gene Nanog.
Overexpression of ABCG2 in ES cells was able to counteract the increase of endogenous PPIX induced by treatment with 5-
Aminolevulinic acid suggesting ABCG2 played a direct role in removal of PPIX from ES cells. We also found that excess PPIX in
ES cells led to elevated levelsof reactive oxygen species which in turn triggered DNA damagesignals as indicated by increased
levels of cH2AX and phosphorylated p53. The increased level of p53 reduced Nanog expression because RNA- interference
mediated inhibition of p53 was able to prevent the downregulation of Nanog induced by FTC treatment.
Conclusions/Significance: The present work demonstrated that ABCG2 protects ES cells from PPIX accumulation during
colony expansion, and that p53 and cH2AX acts as a downstream checkpoint of ABCG2-dependent defense machinery in
order to maintain the self-renewal of ES cells.
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Introduction
Embryonic stem (ES) cells are pluripotent cells derived from the
inner cell mass of blastocysts. Under appropriate culture
conditions, undifferentiated ES cells can be maintained over
many self-renewal cycles without loss of pluripotency [1,2].
Moreover, ES cells are unique in that unlike differentiated cells
they do not accumulate DNA damage during multiple self-renewal
cycles. This feature is important in vivo as a small number of ES
cells can contribute the whole process of embryogenesis, therefore
if DNA damage accumulated in ES cells could potentially affect
development of different tissue types.
One of the major causes of DNA damage in cells is reactive
oxygen species (ROS). Several studies have shown that low/
moderate levels of ROS generated from cell metabolism play an
important role in maintenance physiological functions of cells and
in some cases are even used as the signaling mediator [3].
However, high levels of ROS may cause damages to cell
structures, including lipids and membranes, proteins, and DNA,
which can in turn lead to apoptosis or senescence [4]. In fact, it has
been shown that the mutation frequency in ES cells is low because
ES cells are sensitive to DNA damage and readily undergo
apoptosis or differentiation in order to remove damaged cells from
the self-renewal pool [5–7]. Moreover, in order to prevent
excessive ROS levels ES cells express high levels of antioxidant
defense enzymes as well as high activity of verapamil-sensitive
multidrug transporter [8,9].
The ATP binding cassette transporter ABCG2 is a verapamil-
sensitive multidrug transporter that is expressed in a wide variety of
drug-resistant cancer cells, extrudes xenobiotics and certain drugs
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pharmacological behavior of many compounds [10–12]. Later
studies determined that ABCG2 expression is not unique to drug
resistant cancer cells, but is also expressed in a wide variety of stem
cells and in numerous adult tissues [1,2]. In fact, ABCG2 is also the
molecular determinant of the side-population (SP) phenotype, which
has been widely used for the detection and enrichment of tissue stem
cells [1,10]. ABCG2 was also found to be highly expressed in human
ES cells [13] as well as rhesus monkey ES cells [14]. Interestingly
despite the clear correlation between ABCG2 and stem cells, its exact
function in these cells has not been elucidated.
Recently it has been shown that ABCG2 plays a role in
enhancing the survival of haematopoetic stem cells in hypoxia,
which is possibly mediated through transportation of heme and
porphyrins [15]. Heme is composed of iron and protoporphyrin
IX (PPIX) which is s an essential component of various
hemoproteins, including cytochromes involved in mitochondrial
electron transfer chain and in drug metabolism [16]. Hemes are
also important cofactors in oxygen storage and transport (such as
hemoglobin and myoglobin), signaling mediator (nitric oxide
synthases, guanylate cyclases) and in regulation of antioxidant-
defense enzymes [16,17]. The levels of PPIX in cells are tightly
regulated in many cell types as excess PPIX could undergo the
iron catalyzed fenton reaction and generate potentially DNA
damaging ROS [16]. Recently identified heme/porphyrin trans-
porters such as heme carrier protein 1 (HCP1), FLVCR, ABCB6
and ABCG2 are expected to play an important role in maintaining
a homeostatic level of porphyrins
Developing embryos naturally resides in hypoxic microenviron-
ments and low level of oxygen regulates cell fate decision of
embryonic stem/progenitor cells. Recent work further suggests
undifferentiated mouse ES cells adapt their energy metabolism to
proliferate at different oxygen tension [18]. Cellular adaptations to
changes in oxygen levels include stimulating several hypoxia-
inducible factors that mediate oxygen homeostasis and control the
level of heme, a molecule whose level changes in response to
changes in cellular oxygen [19,20]. ABCG2 expression is
upregulated under low oxygen conditions, which is consistent
with its high expression in tissues exposed to low oxygen
environments [21]. Since ABCG2 interacts with porphyrin
[15,21,22] and elevated levels of PPIX in erythroid progenitors
of ABCG2-deficient mice support the idea that porphyrins are
Figure 1. Inhibition of ABCG2 led to downregulation of Nanog in ES cells. (A) RT-PCR data of ABCG2 in J1, R1, D3 and B6 mouse ES cell lines
as well as in MEFs, with GAPDH as internal control. (B, C) Real-time PCR data showing relative mRNA expression level of ABCG2 (B) and Nanog (C) in
mES-R1 cells treated with or without 10 mM of the ABCG2 inhibitor FTC, normalized to GAPDH. Data was calculated from at least three independent
experiments. A t-test was performed to confirm statistical significance and * indicates p,0.05 (D, E) Immunofluorescence staining showing Nestin
expression was observed in FTC treated mES-R1 cells. (F–T) Immunofluorescence staining for ABCG2, Oct-4 and Nanog in untreated mES-R1 and mES-
J1 cells, in mES-R1 cells treated with 1 mMo r1 0mM of the ABCG2 inhibitor FTC, and in mES-J1 cells treated with 10 mM FTC for 72 hours.
doi:10.1371/journal.pone.0004023.g001
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stasis in ES cells is maintained by ABCG2 in order to adapt to
changes in oxygen availability during rapid colony expansion.
However, if ABCG2 function was disrupted, the accumulation of
PPIX possibly lead to increased level of ROS would therefore
induce DNA damage and then trigger downstream checkpoint
signals, which may in turn cause the ES cell to lose its pluripotency
as well as disrupting the self-renewal cycle.
Results
Inhibition of ABCG2 leads to downregulation of Nanog in
mouse ES cells
No detailed data was available regarding the expression of
ABCG2 in mouse ES cells. Therefore, we first set out to determine
whether ABCG2 is expressed in mouse ES cells. Using RT-PCR,
we found that ABCG2 is expressed in several mouse ES cell lines,
including ES-R1, J1, D3, and B6 (Fig. 1A). The expression levels
varied among the cell lines, with the highest level seen in ES-D3
cells and the lowest level observed in ES-B6 cells.
After establishing the expression pattern of ABCG2 in mouse ES
cells, we next investigated its possible function. To do this, we utilized
the chemical inhibitor fumitremorgin C (FTC), which specifically
inhibits the activity of ABCG2 [24]. Verapamil was not used as it can
also inhibit other multidrug transporter [25,26]. When mouse ES
cells were treated with either 1 or 10 mMF T Cf o r7 2h o u r s ,w e
observed that expression levels of ABCG2 remained similar to those
of control cells (Fig 1B). However, Nanog expression was significantly
downregulated in the 10 mM FTC-treated cells, as observed by both
Immunofluorescence staining and real-time RT-PCR (Fig. 1C, F–T).
Wewerealsoabletodetectexpressionoftheearlyectodermalmarker
Nestin in FTC treated mES cells indicating perhaps that some of the
ES cells have started to undergo differentiation.
To confirm whether the downregulation of Nanog was
specifically caused by inhibition of ABCG2, we designed two
shRNA constructs based on RNAi Codex database [27]:
shABCG2-2 and shABCG2-3, which specifically target the 59
and 39 ends of ABCG2. Transfection with shABCG2-2 or
shABCG2-3 reduced Nanog expression in ES cells (Fig. 2E, G).
Immunofluorescence staining confirmed the downregulation of
ABCG2 by the shRNA constructs (Fig. 2C–D). As shown in
Fig. 2C, GFP (a marker of transfection) colocalized with low levels
of ABCG2 staining demonstrating that transfection with
shABCG2-3 downregulated ABCG2 expression in these mouse
ES cells. Expression of Oct-4 was not altered significantly in
shABCG2-3 transfected cells, as there were no GFP-positive cells
that colocalized with reduced Oct-4 staining (data not shown).
However, expression of Nanog was downregulated in shABCG2-3
transfectants (Fig. 2D). RT-PCR of GFP-sorted transfected cells
confirmed this data (Fig. 2E) and utilizing real-time PCR we found
that transfection with both shABCG2 construct was sufficient to
reduce ABCG2 expression by approximately 70% (Fig. 2F).
Nanog expression was reduced by approximately 60% (Fig. 2G).
This result was consistent with the results that were obtained
through chemical inhibition of ABCG2. Based on these it appears
that ABCG2 is regulating the expression of Nanog.
Figure 2. Knock-down of ABCG2 led to downregulation of Nanog. (A–D) Immunofluorescence staining for mES-R1 cells transfected with
control scramble construct (A, B) and shABCG2-3 construct (C, D) and. The GFP marked transfected cells and red represented ABCG2 (A, C) and Nanog
(B, D) staining. Immunofluorescence staining was performed at 72 hours after transfection. Images represent transfections with either shABCG2-2 or
shABCG2-3. (E) RT-PCR data for Oct-4, Nanog and ABCG2 for mES-R1 cells transfected with scrambled, shABCG2-2 or shABCG2-3 with GAPDH as
internal control. (F, G) Real-time PCR data showing relative mRNA expression level of ABCG2 (F) and Nanog (G) in mES-R1 cells transfected with
scrambled, shABCG2-2 or shABCG2-3 normalized to GAPDH. A t-test was performed to confirm statistical significance and * indicates p,0.05 and **
indicates p,0.01. Data was calculated from at least three independent experiments.
doi:10.1371/journal.pone.0004023.g002
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inhibition
To investigate further the effect of ABCG2 inhibition in ES cells
we decided to perform a time-course experiment, analyzing the
expression of Oct-4 and Nanog at 24, 72 and 120 hours after
addition of FTC. Results of time course experiments suggest that
after 5 days of FTC treatment, the reduced expression of Nanog
possibly led to the subsequent reduction of its downstream target,
Oct-4 (Fig. 3A–L, M). Cell growth was also suppressed by FTC
treatment after 72 hours of treatment as shown by the growth
curve (Fig. 3N). To identify the cause of the reduced growth rate
we analyzed the cell cycle profile of untreated and FTC treated
cells (Fig. 3O). Here we found the percentage of FTC-treated cells
in S phase was higher than that seen in control cells at 72 hours
after addition of FTC (70.83%61.02%vs 64.74%60.31%). We
also observed a decrease in the percentage of cells in G2/M phase
in the 10 mM FTC-treated samples compared with control
samples (7.25%60.91% vs 13.36%62.53%), while the percent-
ages of cells in G1 remained relatively similar between FTC-
treated and untreated samples (21.92%61.19% vs
21.90%62.85%). Taken together this would indicate that there
is an S-phase cell cycle arrest in FTC treated mouse ES cells.
ABCG2 expression levels during colony expansion is
correlated with cytosolic PPIX levels
RT-PCR data from the time course experiment also revealed
that ABCG2 expression levels were increased as the colony
expands (Fig. 2M). We then wondered if this increase in ABCG2
expression could be correlated with the levels of its substrates-
porphyrins. Time course experiments showed that increases in the
levels of ABCG2 during colony expansion were followed by a
decrease in PPIX levels (Fig. 2N), indicating that ABCG2 might
play a role in porphyrin homoeostasis in expanding colonies.
We constructed an overexpression construct by putting a full-
length mouse ABCG2 in the mammalian expression vector
pCMS-EGFP. We found no difference in the levels of Oct-4 and
Nanog in ES cells transfected with this construct (Fig. 4A–C)
despite the cellular levels of ABCG2 being increased by
approximately 60% (Fig. 4B, C). However, overexpression of
ABCG2 decreased the endogenous level of PPIX suggesting
ABCG2 might play a role in transportation of cytosolic porphyrins
(Fig. 5A).
ABCG2 inhibition leads to accumulation of PPIX and
elevated levels of ROS
In order to determine whether ABCG2 is involved in the
transportation of cytosolic porphyrin in ES cells, we measured the
level of cellular PPIX in ES cells treated with either 1 mM d-
aminolevulinic acid (ALA) or 10 mM FTC as well as transfection
of shABCG2 constructs. ALA is a known precursor of PPIX
[20,28,29], which indeed induced accumulation of PPIX in ES
cells (Fig. 5D). As expected, when ABCG2 was inhibited with
either shABCG2 or FTC we see an increase in the level of cellular
PPIX (Fig. 5B, C). However, these measurements were done on
ES cells that have been grown for 4 days. In order to confirm that
accumulation of PPIX in ES cells was directly due to lack of PPIX-
transportation by ABCG2, we needed to perform the assay over a
shorter period. We decided to do this by inducing high levels of
PPIX in ES cells with 1 mM ALA treatment and allowing 1 hour
for efflux. Here, we observe that FTC treated as well as shABCG2
inhibited ES cells did show a reduced ability to efflux PPIX
(Fig. 5E, G). Conversely, overexpression of ABCG2 in ES cells
increased their ability to efflux PPIX (Fig. 5F). These finding
suggests that ABCG2 possibly play an important role in
maintaining PPIX homeostasis in ES cells.
At this point we decided to see if this accumulation of PPIX was
the cause for the phenotype seen in ABCG2 inhibited ES cells. We
induced high levels of PPIX in ES cells with 2-hour brief treatment
with 1 mM ALA and allowing 2 days for ES cells to adapt. We
found that the level of Nanog was significantly reduced indicating
accumulation of PPIX by itself without ABCG2 inhibition directly
lead to downregulation of Nanog.
Elevated levels of ROS by excess PPIX activated DNA
damage signals
It has been shown that ROS can be generated by oxidation of
the porphyrin precursor ALA [30] or by the fenton reaction
involving PPIX [16]. Since both ALA and FTC treatment
increased the level of PPIX, it would follow that they would lead
to increased levels of reactive oxygen species (ROS). Indeed this
was what we observed in 10 mM FTC treated, and ALA treated
mES cells (Fig. 5J–L). RT-PCR analysis further revealed that
superoxide dismutase 2 (SOD2), thioredoxin (TRX), and gluta-
thione peroxidase 2 (GPX2) levels were reduced after FTC
treatment, indicating that the endogenous expression of genes
involved in oxidative stress defense was not sufficient to remove
excessive ROS (Fig. 6A).
Since ROS are a major source of DNA damage, we
hypothesised that elevated ROS in ES cells may trigger DNA-
damage signals. Time course experiments confirmed that
suppression of the ABCG2 transporter with FTC did in fact
increase the level of phosphorylated H2AX (cH2AX) (Fig. 6B, D).
This suggests that DNA double strand breaks (DSBs) had
occurred, which may explain the cell cycle arrest at S phase we
observed in (Fig. 3O). Furthermore, ES cells with oxidative
damage demonstrated a reduction of Nanog accompanied by
phosphorylation of ataxia telangiectasia mutated (ATM) at Ser
1981. This in turn led to an increase in the level of p53 and p53
phosphorylation at ser18, ser23, and ser389 (Fig. 6B) in response
to DNA damage signals [31–33].
Downregulation of Nanog in ABCG2 inhibited ES cells is a
p53 dependent pathway
Previous studies have shown that p53 binds to the promoter of
Nanog and suppresses Nanog expression after UV-induced DNA
damage. We observed nuclear localization of p53 (Fig. 6F),
therefore we want to determine whether the downregulation of
Nanog in ABCG2-inhibited ES cells was directly mediated by p53,
we generated a GFP-labelled ES cell line containing a Cre-lox-
regulated p53 RNA interference construct (named J1_pSico-P53,
Figure 3. Time course experiments revealed inhibition of ABCG2 for longer period downregulated Nanog and Oct-4 and led to cell
cycle arrest at S phase. (A–L) Immunofluorescence staining for Nanog and Oct-4 on untreated and 10 mM FTC-treated mES-R1 cells at 24, 72 and
120 hours after addition of FTC. (M) RT-PCR data for ABCG2, Nanog and Oct-4 in untreated and FTC-treated mES cells at 24, 72 and 120 hours after
addition of FTC, with GAPDH as internal control. (N) Growth curves of untreated mES-1 cells and cells treated with 1 mMo r1 0mM FTC at 24, 72 and
120 hours after addition of FTC. Error bars represent 1 standard deviation calculated from 3 separate experiments. (O) Cell cycle profile based on PI
staining of untreated and 10 mM FTC-treated mES-R1 cells at 72 hours after addition of FTC. Diagram shown represents at least 3 separate
experiments. (P) Time course of PPIX expression level in mouse ES cells showing the gradual decrease of PPIX.
doi:10.1371/journal.pone.0004023.g003
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led to recombination, with loss of GFP fluorescence within 2 days
accompanied by expression of p53-shRNA and decreases in the
level of p53 (data not shown), which did not alter the level of
Nanog significantly. FTC treatment dramatically suppressed
Nanog expression in J1_pSico-P53 ES cells (Fig. 7C). In contrast,
Figure 4. Overexpression of ABCG2 did not alter the level of Nanog and Oct-4. (A, B) Immunofluorescence staining for mES-R1 cells
transfected with CMS-ABCG2. The GFP marks transfected cells and red represents Oct-4 (A) and Nanog (B) Immunofluorescence staining at 72 hours
after transfection. (C) RT-PCR data for Oct-4, Nanog and ABCG2 for mES-R1 cells transfected with control vector or CMS-ABCG2 with GAPDH as
internal control. (D) Real-time PCR showing relative mRNA expression level of ABCG2 in mES-R1 cells transfected with control vector or CMS-ABCG2
normalized to GAPDH. Data was calculated from at least three independent experiments.
doi:10.1371/journal.pone.0004023.g004
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PLoS ONE | www.plosone.org 7 December 2008 | Volume 3 | Issue 12 | e4023the combined treatment with HTNCre and FTC showed that
p53-shRNA-expressing cells (GFP-negative cells, arrows in Fig. 4E)
maintained the expression of Nanog that is higher compared to
adjacent GFP-positive cells, which did not express p53-shRNA
(arrow heads in Fig. 6E). These results confirm that p53 mediates
the downregulation of Nanog in ABCG2-inhibited ES cells.
Discussion
The ABCG2 multidrug-transporter is widely expressed in a
variety of tissue stem cells and cancer stem cells, suggesting that it
plays an important role in self-renewal maintenance. We have
identified an endogenous role of ABCG2 in maintaining the self-
renewal of ES cells during self-renewal cycles. We demonstrate
that disruption of ABCG2 function in ES cells can lead to
accumulation of PPIX over time. This idea is supported by the fact
that porphyrins accumulate in tissues of the BCRP knockout
mouse [23]. One of the consequences of the accumulation of PPIX
is elevated ROS level in ES cells leading to an increased potential
for DNA damage (Fig. 8).
Indeed, we found an increase in both cH2AX and pATM levels
in ABCG2 inhibited ES cells, indicating DNA damage. Phosphor-
ylation of ATM in response to ROS induced DNA damage leads to
the activation of p53 [4,35]. It has been shown that ES cells do not
have G1 checkpoints and only undergo p53-independent apoptosis
after certain types of physiological DNA damage, possibly due to
p53 being sequestered in the cytoplasm unless SIRT1 is inhibited
[36,37]. Hence the cell cycle arrest we observed is likely caused by
cH2AX, preventing proliferation of DNA damaged ES cells.
Furthermore,wedidnot observe significantincreasesofapoptosisin
ABCG2-inhibited ES cells. In contrast, we obtained a dramatic
upregulation in the nuclear level of p53, which was able to suppress
Nanog expression in ABCG2-inhibited ES cells. The findings
probably resulted from direct binding of PPIX to p53, which
disrupts the interaction between p53 protein and its negative
regulator such as HDM2 [38]. This represents an alternative
pathway formaintaininggeneticstabilityinEScells[39].Consistent
with this notion, our current work has confirmed that p53 can
suppress Nanog expression in response to accumulated levels of
PPIX and ROS and then trigger the differentiation of ‘‘damaged’’
ES cells into nestin-expressing cells, which effectively removes the
damaged cells from the self-renewal pool.
Recent findings have indicated that the PI3K/Akt signaling
pathway regulates the surface expression of ABCG2 [40] and may
be involved in regulating the pluripotency of ES cells. Inhibition of
PI3K with the PI3K inhibitor LY294002 in mouse ES cells
reduced self-renewal growth and downregulated Nanog expression
[41]. Likewise, we found that treatment of mouse ES cells with the
PI3K inhibitor-LY294002 led to inhibition of the side-population
phenotype (data not shown) as well as downregulation of Oct-4
and Nanog expression (Fig. 9A, B, D, E), which is consistent with
previously published results. Moreover, we discovered that the
expression of ABCG2 was also downregulated in these LY294002-
treated ES cells (Fig. 9C, F), suggesting that ABCG2 acts
downstream of PI3K.
E Sc e l l sh a v eah i g hp r o l i f e r a t i v er a t e ,a l l o w i n gf o rr a p i de x p a n s i o n
of ES colonies, which we speculate may reduce oxygen availability
and resulted in alteration of heme synthesis and metabolism in some
ES cells. Indeed we found a brief hypoxic treatment (10% O2 for
2 hours) led an increase in both the cytosolic level of PPIX and ROS
(Fig.8G, H)in EScells.In accordance with this, we speculate that the
variance seen in the expression of ABCG2 in different mES cells
could be correlated with their oxygen availability and proliferation
rate. Indeed, from the four different mES cells tested B6 is known to
have a slower proliferation rate compared to R1 and J1, which might
explain the lower ABCG2expression seen in B6 compared to R1 and
J1. Furthermore, ABCG2 have also been shown to enhance cell
survival under hypoxia [15] and contain at least one functional
hypoxia response element in its promoter [12], which would suggest
an involvement of hypoxia-inducible factors in the regulation of
ABCG2. This hypothesis is supported by a recent study, which
discovered transactivation of ABCG2 by hypoxia-inducible factor 2
a l p h ai nc a r d i a cS Pc e l l s[ 4 2 ] .A l s o ,c o n s i d e r i n gt h a tP P I Xl e v e l sa r e
increased during hypoxia it makes it very likely that hypoxia-
inducible factors might be involved in regulating ABCG2 levels with
respect to regulate PPIX homeostasis.
In conclusion, we have demonstrated here for the first time that
the ABCG2 transporter plays a role in preventing porphyrin
accumulation in ES cells and excessive production of ROS from
heme metabolism during colony expansion. When this function is
inhibited, excess PPIX would lead to trigger DNA damage signals
such as pATM, pp53 and cH2AX, which function as downstream
checkpoints to ensure that the genetic integrity of ES cells is
maintained and/or to eliminate ES cells with damaged DNA from
the self-renewal pool.
Materials and Methods
ES cell culture
Wild type ES cell lines R1, J1, D3 and B6 were cultured on
mitotically inactivated mouse embryonic feeder (MEF) cells in
Dulbecco’s Modified Eagle medium (DMEM, Hyclone) with 10%
ES quality foetal bovine serum (FBS; Hyclone), 1 mM sodium
pyruvate (Gibco), Penicillin (100units/ml)/Streptomycin (100 mg/
ml) (Gibco), 5.5610
22 mM b-mercaptoethanol, (Calbiochem) and
10
3 U/ml LIF (Chemicon). Embryoid bodies (EBs) were formed
by seeding the ES cells at densities of 500–2000 cells/cm
2 on
uncoated plates.
Inhibitor Treatment
The chemical inhibitors LY294002 (Sigma) and Fumitremogrin
C (Calbiochem) were added to the ES growth media 24 hours
after the ES cells were seeded on MEF cells (day 1). The media
containing inhibitors was changed daily to ensure activity. Cells
were treated for various time periods before being subjected to
immunostaining or RT-PCR analysis.
PPIX and ROS measurements
mES cells were harvested using Collagenase IV (Sigma) for
5 minutes at 37uC and washing once with staining buffer (HBSS;
Figure 5. Inhibition of ABCG2 resulted in increases in PPIX and ROS levels. (A–D) PPIX fluorescence measured by flow cytometry for control
vector and CMS-ABCG2 (A), scramble and shABCG2 transfected ES cells (B) as well as untreated and 10 mM FTC-treated mES-R1 cells 96 hours after
addition of FTC (C). For positive control, mES-R1 cells were treated with 1 mM 5-aminovaleric acid (ALA) for 1 hour to induce production of PPIX (D).
Diagram shown represents at least three independent experiments. (E–G) Cytosolic PPIX level measurements after induction with 1 mM ALA for
30 minutes and efflux for 1 hour for Untreated and 10 mM FTC (E) treated mES-R1 control vector and CMS-ABCG2 transfected mES-R1 (F) and
scramble and shABCG2 transfected mES-R1(G). (H, I) Immunofluorescence staining showing downregulation of Nanog in untreated (H) as well as 2-
hour ALA treated (I) mES cells. (J–L) ROS level measurements by flow cytometry using the ROS sensitive dye DCFH-DA for untreated and 1 mM (J) and
10 mM (K) FTC-treated mES-R1 cells as well as 2-hour treatment with ALA (L). Diagram shown represents at least three independent experiments.
doi:10.1371/journal.pone.0004023.g005
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PLoS ONE | www.plosone.org 8 December 2008 | Volume 3 | Issue 12 | e4023Figure 6. Inhibition of ABCG2 resulted in increases in levels of cH2AX, p53, phosphorylated p53 and phosphylated ATM. (A). RT-PCR
data for genes involved in oxidative stress defense: SOD2, SOD4, TRX, and GPX2, with GAPDH as internal control for untreated and 10 mM FTC-treated
mES-R1 cells 72 hours after addition of FTC. (B) Western blot of 10 mM FTC-treated mES-J1 cells stained for Nanog, cH2AX, p53 and Phospho-p53
Ser18, 23 and 389 as well as ATM and Phospho-ATM ser1981. Equal amounts of protein were used (40 mg per lane). (C–F) Immunofluorescence
staining for cH2AX (C, D) and p53 (E, F) in untreated and 10 mM FTC treated mES-R1 cells taken at 72 hours after addition of FTC.
doi:10.1371/journal.pone.0004023.g006
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protoporphyrin IX and ROS concentrations were assessed using a
Vantage flow cytometer (BD Biosciences). Endogenous PPIX
levels were measured by using UV laser excitation and measuring
the emission using a 635 nm filter with Vantage flow cytometry
(BD Biosciences). To determine the ROS levels, mES cells were
Figure 7. Knock-down of p53 prevented downregulation of Nanog in ABCG2-inhibited ES cells. (A–D) Immunofluorescence staining for
Nanog on untreated (A, B) and 10 mM FTC-treated (C, D) J1_pSico-p53 cells with (B, D) or without (A, C) the addition of HTNCre to activate inhibition
of p53. White arrows indicate GFP negative cells with high Nanog where p53 inhibition has rescued Nanog expression. Arrowheads indicate GFP
positive cells with low or no Nanog.
doi:10.1371/journal.pone.0004023.g007
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HBSS (Gibco) for 30 minutes at 37uC, and were washed twice
with staining buffer before measurement using Callibur flow
cytometry (BD Biosciences) with an FITC emission filter.
PPIX efflux
To determine the ability of cells to efflux PPIX, mES cells were
incubated for 30 minutes at 37uC in ES media with 1 mM ALA
followed by a further 1 hour incubation in ES media with or
without inhibitors before measurement of PPIX levels by using
UV laser excitation and measuring the emission using a 635 nm
filter with Vantage flow cytometry (BD Biosciences).
Plasmids construction and transient transfection
Two different shRNAs, shABCG2-2 and shABCG2-3, were
designed to target within the ABCG2 CDS region (see Table 1 for
sequence), and were cloned into the pDsiPHER-GFP plasmid
(Molecula). A scrambled version of shABCG2-2 was also made for
control. The ABCG2 overexpression vector was constructed by
subcloning a full-length mouse ABCG2 cDNA obtained from
Figure 8. Summary of proposed role of ABCG2 in mouse ES cells. Diagram illustrating how inhibition of ABCG2 could lead to accumulation of
PPIX and elevated levels of ROS, which in turn caused DNA damage and eventually activating p53 and cH2AX, Activation of p53 lead to
downregulation of Nanog whilst cH2AX causes cell cycle arrest. Also depicted in the diagram is possible involvement of PI3K/AKT a well as hypoxia in
this pathway.
doi:10.1371/journal.pone.0004023.g008
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vector pCMS-EGFP (Clontech). Once constructed, the plasmids
were transfected into the ES cells using Fugene HD transfection
reagent (Roche). The ES cells were then cultured for another 48-
72 hours before immunostaining or sorting using BD FACS Aria
cell sorter for GFP to use for RT-PCR.
Establishment of J1_pSico-p53 ES cell lines
J1 mouse ES cells were seeded on 6 cm tissue culture plates with
mitomycin C inactivated MEF. On day 1, cells were infected with
lentivirus-pSico_p53 and polybrene 8 mg/ml and were left
overnight. Cells were then washed with PBS, incubated in ES
media, and cultured for an additional 3 days. To select for
Figure 9. ABCG2 possibly play as a downstream mediator of PI3K/AKT in the self-renewal of ES cells. (A–F) Immunofluorescence
staining for ABCG2, Oct-4 and Nanog for untreated and 10 mM LY294002 treated mES-R1 taken at 72 hours after addition of LY294002. Here we can
see that ABCG2 was downregulated when PI3K was inhibited (G) PPIX fluorescence measures showing an increase in 2 hour-hypoxia treated mES-R1
cells compared to control cells. (H) DCFH-DA staining showing increase in the ROS levels in 2 hour-hypoxia treated mES-R1 compared to control cells.
doi:10.1371/journal.pone.0004023.g009
Table 1. shABCG2 and scramble control sequence.
Target Sense
shABCG2-2 GATCCGGATTAACACAATCATTAATTCAAGAGATTAATGATTGTGTTAATCCTTTTTTA
shABCG2-3 GATCCGCCCTGGCTTGTATGATTATTCAAGAGATAATCATACAAGCCAGGGCTTTTTTA
scramble GATCCGGTCGAATTTGCGAACCAATTCAAGAGATTGGTTCGCAAATTCGACCTTTTTTA
doi:10.1371/journal.pone.0004023.t001
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collagenase IV then trypsinized by 0.1% trypsin and sorted for
GFP signal in BD FACS Aria cell sorter. The GFP positive J1-
pSico_p53 cells were grown on mitomycin C inactivated MEF for
further use.
In order to produce pSico_p53 lentivirus, the day prior to
transfection, confluent 10-cm plates of 293T cells were seeded at
2.4610
6 cells/plate. The expression plasmid pSico_p53 was
obtained from Addgene (plasmid 12089) [43]. For each 10-cm
dish, 7.5 mg expression vector, 6.75 mg pCMV-D8.91 packaging
plasmid, and 0.75 mg pMD.G envelope were transfected using
Genejuice transfection reagent (Novagen). The day after transfec-
tion, the media was replaced with fresh media. Culture
supernatant was subsequently harvested at 48, 72 and 96 hours
post-transfection. Virus-containing supernatant was filtered
through 0.45 mm pore filters and stored at 4uC. Virus was further
concentrated by ultracentrifugation for 2.5 hours at 26 000 rpm
in a Beckman SW 28.1 rotor (Beckman Coulter), and the resulting
virus pellet was resuspended in PBS (pH 7.4) containing 1% BSA
at 4uC overnight before being aliquoted and stored at 280uC.
HTNcre Cre treatment of J1_pSico-p53
Sorted J1_pSico-p53 cells were cultured in HTNCre containing
medium (5 mM) overnight, were washed twice with PBS, and then
treated with FTC 10 mM for 3–4 days before immunostaining.
HTNCre protein was produced as previously described [44].
Immunofluorescence Staining
Cells were fixed in 4% paraformaldehyde for 30 minutes at
room temperature and permeabilized at room temperature in
0.1% Triton X-100 for 30 minutes. After blocking with 2% Roche
blocking reagent, the cells were incubated with primary antibody
overnight at 4uC and with secondary antibody for 2 hours at room
temperature. The primary antibodies were used at the following
dilutions: Oct4 (1:200, Santa Cruz); Nanog (1:150, Reprocell);
Carbonyl (1:62, Chemicon Oxyblot kit); Nestin (1:300, Chemi-
con); ABCG2 (1:75, Chemicon); p53 (1:300, Santa Cruz); cH2AX
(1:200, Upstate). The secondary antibodies were used at the
following dilutions: goat anti-rabbit fluorescein (1:300, Chemicon),
goat anti-mouse fluorescein (1:300, Vectorlabs), goat anti-rabbit
Texas Red (1:300, Vectorlabs) and goat antimouse Texas Red
(1:300, Vectorlabs). Images of the immunostaining were obtained
using a SPOT camera mounted on a Zeiss Axioplan 2 microscope.
RT-PCR and real-time PCR
Cells used for RT-PCR experiments were washed once with
PBS before RNA extraction with Trireagent (Ambion) per
manufacturer’s instructions. 5 mg of the purified RNA was then
subjected to reverse transcription using Superscript III (Invitrogen)
per manufacturer’s instructions to obtain cDNAs for PCR. Real-
time PCR was performed using Lightcycler 2.0 (Roche) with the
SYBR green Taqman master kit (Roche) per manufacturer’s
instructions. Details of the sequence of primers used in PCR can
be found in Table 2.
SDS-PAGE and Immunoblot Analysis
Samples were separated by SDS-PAGE (10%) and subsequently
transferred to PVDF Immobilon-P membrane (Millipore). Sam-
ples were incubated in blocking buffer (0.1% Tween 20, 5%
nonfat milk powder in TBS) for 1 hour at room temperature.
Afterwards, the membrane was incubated with primary antibody
in blocking buffer overnight at 4uC before being washed twice with
TBST (0.1% Tween in TBS) and incubated with the appropriate
secondary antibody in blocking buffer for 1 hour at room
temperature. The blot was developed using the Western
Chemiluminescent HRP substrate (Immobilon). The primary
antibodies were used at the following dilutions: Nanog (1:400,
Reprocell); p53 (1:400, Cell Signaling), p53-Ser15p (1:400, Cell
Signalling), p53-Ser20p (1:400, Cell Signaling), p53-Ser392p
(1:400, Cell Signaling), ATM (1:200, Cell Signaling), pATM-
Ser1981 (1:250, Cell Signaling); cH2AX (1:400, Upstate). The
secondary antibodies used were anti-rabbit HRP (1:1000, Santa
Cruz) or anti-mouse HRP (1:1000, Santa Cruz).
Cell Cycle Profile
Mouse ES cells were harvested with Collagenase IV (Sigma) and
washed once with PBS before being fixed with dropwise addition
of 1 ml ice cold 70% EtOH and incubated overnight at 220uC.
The following day, the cells were washed once with PBS and
stained with cell cycle staining buffer (1% Triton X-100 (Sigma),
0.2 mg/ml RNAse A (Promega) and 0.02 mg/ml propidium
iodide in PBS) for 30 minutes at room temperature. The cells were
then washed twice with PBS before propidium iodide fluorescence
was measured using Callibur flow cytometry (BD Biosciences).
Thepercentages of cells in each phase of the cell cycle were
calculated using the Modifit LT software package.
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